NASA Administrator, New Head of Human Spaceflight Host Media Teleconference
WASHINGTON, June 15, 2020 /PRNewswire/ -- NASA Administrator Jim Bridenstine will host a media teleconference at 1 p.m. EDT Friday, June 19, to introduce Kathy Lueders, the newly selected associate administrator of the agency's Human Exploration and Operations Mission Directorate.
To participate in the teleconference, media should contact Josh Finch at [email protected] by 10 a.m. Friday, June 19, to receive the dial-in information.
Audio of the teleconference will stream live online at:
Prior to her appointment as the head of NASA's human spaceflight office, Lueders served as the program manager for the agency's Commercial Crew Program. Since 2014, she has worked with private industry to develop, test and fly next-generation American human space transportation systems to low-Earth orbit, including to the International Space Station.
For information about NASA's Human Exploration and Operations Mission Directorate, visit:
Trakx, an emerging global fintech company providing thematic Crypto Tradable Indices ("CTIs"), today announced the launch of the Trakx USDc Earn CTI powered by OpenTrade that is designed to allow users to easily generate high risk-adjusted returns on...
Aiming at offering greater enjoys for customers with products that have less harmful effects on the environment and more benefits on sustainable power generation, Astronergy upgraded its residential products ? ASTRO N7s again with less redundant...
Aetina, a leading Edge AI solution provider, announced the launch of the Aetina IA380E-QUFL at Embedded World 2024 in Nuremberg, Germany. This groundbreaking product is a small form factor PCIe graphics card powered by the high-performance Intel Arc...
A novel ice hockey puck with an integrated chip is revolutionising the world of sport. The Swiss ice hockey puck, known as an "Eisgenoss", which is being issued in a limited edition of gold, silver and conventional hard rubber, marks the beginning of...
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...
Crossover Markets Group, Inc., a digital asset technology firm focused on meeting the unique liquidity requirements of institutions, today announced several key performance indicators from Q1 trading on its flagship digital assets platform CROSSx....
